Company profile for Vaxcyte

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Vaxcyte is a vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. The Company is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Vaxcyte’s lead candidate, VAX-24, is a 24-valent, broad-spectrum pneumococcal conjugate vaccine being developed for the prevention of invasive pneumococcal di...
Vaxcyte is a vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. The Company is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Vaxcyte’s lead candidate, VAX-24, is a 24-valent, broad-spectrum pneumococcal conjugate vaccine being developed for the prevention of invasive pneumococcal disease. Vaxcyte is re-engineering the way highly complex immunizations are made through modern synthetic techniques.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
825 Industrial Road, Suite 300 San Carlos, CA 94070
Telephone
Telephone
(650) 837-0111
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/04/3180843/0/en/Vaxcyte-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Business-Update-Including-Final-Data-from-Positive-VAX-24-Infant-Phase-2-Dose-Finding-Study.html

GLOBENEWSWIRE
04 Nov 2025

https://www.fiercepharma.com/manufacturing/vaxcyte-strikes-1b-deal-fill-finish-space-thermo-fishers-nc-production-facility

FIERCE PHARMA
03 Oct 2025

https://www.globenewswire.com/news-release/2025/09/30/3158591/0/en/Vaxcyte-to-Establish-Fill-Finish-Manufacturing-in-North-Carolina-as-Key-Element-of-Long-Term-United-States-Commercial-Supply-Strategy-Representing-Up-to-1-Billion-in-Manufacturing-.html

GLOBENEWSWIRE
30 Sep 2025

https://www.globenewswire.com/news-release/2025/08/06/3128686/0/en/Vaxcyte-Reports-Second-Quarter-2025-Financial-Results-and-Provides-Business-Update-Highlighting-Key-Clinical-and-Regulatory-Progress-for-VAX-31-a-Potential-Best-in-Class-Pneumococc.html

GLOBENEWSWIRE
06 Aug 2025

https://www.globenewswire.com/news-release/2025/05/07/3076529/0/en/Vaxcyte-Reports-First-Quarter-2025-Financial-Results-and-Provides-Business-Update.html

GLOBENEWSWIRE
07 May 2025

https://www.globenewswire.com/news-release/2025/05/01/3072338/0/en/Vaxcyte-Appoints-Dr-Olivier-Brandicourt-to-Board-of-Directors.html

GLOBENEWSWIRE
01 May 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty